Report of the External Review Committee for the Institute of Medical Science the University of Tokyo March 2021
Total Page:16
File Type:pdf, Size:1020Kb
Report of The External Review Committee for The Institute of Medical Science The University of Tokyo March 2021 Contents Prologue (1) Goals and aim for External Review of IMSUT ............................................................................... 6 (2) Period of Review ............................................................................................................................. 6 (3) External Review Method ................................................................................................................. 6 (4) List of External Review of IMSUT Committee Members .............................................................. 7 I. General Statement: Current Status of IMSUT (1) Mission and Features ....................................................................................................................... 9 (2) Organization .................................................................................................................................. 10 (3) Status of Current Research Activities ............................................................................................ 11 1) Implementation System and Support/Promotion System for Research ...................................... 11 2) Initiatives and quality improvement in research activities ......................................................... 17 3) Academic Papers/Patents/Conference Presentations etc. ............................................................ 27 4) Research Funds ........................................................................................................................... 31 5) Research Activities through International Collaboration ............................................................ 35 6) Contribution to Academic Community ....................................................................................... 36 (4) Status of Research Results ............................................................................................................ 39 (5) Status of Education Activity .......................................................................................................... 43 (6) Status of Social Cooperation ......................................................................................................... 43 (7) Issues and Future Prospects ........................................................................................................... 46 II. Detailed Exposition Department of Microbiology and Immunology .................................................................................. 49 Division of Virology ....................................................................................................................... 51 Division of Infectious Genetics ...................................................................................................... 55 Division of Molecular Virology ...................................................................................................... 57 Division of Vaccine Science ........................................................................................................... 60 Division of Malaria Immunology ................................................................................................... 63 Department of Cancer Biology ........................................................................................................... 66 Division of Molecular Pathology .................................................................................................... 69 Division of Cellular and Molecular Biology (-2020.3) ................................................................... 73 Division of Genetics ....................................................................................................................... 76 Division of Cancer Cell Biology ..................................................................................................... 79 Department of Basic Medical Sciences .............................................................................................. 82 1 Division of Molecular Cell Signaling (-2017.3) ............................................................................. 84 Division of Neuronal Network ........................................................................................................ 86 Division of Cell Signaling and Molecular Medicine ...................................................................... 88 Human Genome Center....................................................................................................................... 90 Laboratory of DNA Information Analysis (-2020.3) ...................................................................... 93 Laboratory of Genome Technology ................................................................................................ 93 Laboratory of Genome Database .................................................................................................... 93 Laboratory of Sequence Analysis ................................................................................................... 93 Division of Computational Science (Health Intelligence Center) (-2020.3) ................................... 93 Laboratory of Molecular Medicine ................................................................................................. 96 Laboratory of Functional Analysis in Silico ................................................................................... 99 Department of Public Policy ......................................................................................................... 102 Division of Medical Data Informatics .......................................................................................... 104 Division of Health Medical Intelligence ....................................................................................... 106 Division of Metagenome Medicine............................................................................................... 110 Center for Experimental Medicine and Systems Biology ................................................................. 112 Laboratory of Developmental Genetics (-2018.3) ........................................................................ 115 Division of Stem Cell Pathology .................................................................................................. 117 Laboratory of Innate Immunity ..................................................................................................... 120 Laboratory of Reproductive Systems Biology .............................................................................. 122 Laboratory of Systems Biology (-2019.3) .................................................................................... 124 Division of Genome Engineering ................................................................................................. 126 Advanced Clinical Research Center ................................................................................................. 128 Division of Molecular Therapy ..................................................................................................... 130 Division of Cellular Therapy ........................................................................................................ 133 Division of Infectious Diseases .................................................................................................... 136 Division of Clinical Genome Research ......................................................................................... 139 Division of Innovative Cancer Therapy ........................................................................................ 142 Division of Advanced Medicine Promotion .................................................................................. 144 Division of Advanced Genome Medicine ..................................................................................... 146 Division of Genetic Therapeutics (-2018.3) .................................................................................. 148 Division of Bioethics .................................................................................................................... 150 Center for Stem Cell Biology and Regenerative Medicine ............................................................... 153 Division of Stem Cell and Molecular Medicine ........................................................................... 156 Division of Regenerative Medicine .............................................................................................. 158 Division of Stem Cell Transplantation .......................................................................................... 161 2 Division of Stem Cell Processing/Stem Cell Bank ....................................................................... 163 Division of Stem Cell Signaling ................................................................................................... 165 Division of Stem Cell Dynamics (-2019.3) .................................................................................. 168 Division of Stem Cell Cellomics (-2019.5) .................................................................................. 171 Division of Experimental Pathology ............................................................................................. 173 Division of Stem Cell Biology .....................................................................................................